This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_OVARY_MUCINO_EXALLC for full statistics.
Mucinous and mucinous cystic tumor
C3_OVARY_MUCINO
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
151 |
4. Check minimum number of eventsNone |
151 |
5. Include endpointsNone |
151 |
6. Filter based on genotype QC (FinnGen only) |
151 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Mucinous and mucinous cystic tumor
based on the number of shared cases.
Similar with more cases:
- Mucinous and mucinous cystic tumor, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of ovary
- Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)
- malignant neoplasm of female genital organs
- malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 151 | 151 | - |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | - |
| Median age at first event (years) | 51.58 | 51.58 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 142
- Matched controls
- 1420
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C56.72
ICD-10 Finland
Mucinous epithelial carcinoma of the ovary
+∞
155.0
119
*
8470/3-C56.9
ICD-O-3
Mucinous cystadenocarcinoma, NOS, of ovary
+∞
114.6
94
*
8480/3-C56.9
ICD-O-3
Mucinous adenocarcinoma of ovary
+∞
53.6
48
*
JAL30
NOMESCO Finland
Omentectomy
95.2
46.9
50
8
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
36.0
38.8
50
21
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
238.7
36.6
36
*
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
39.1
33.5
42
15
128
Kela drug reimbursment
Cancers of female genital organs
28.7
29.5
40
19
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
22.3
29.1
43
27
JEA00
NOMESCO Finland
Appendectomy
14.4
28.5
51
53
LCD00
NOMESCO Finland
Hysterectomy
13.8
26.9
49
52
C56
ICD-10 Finland
Malignant neoplasm of ovary
90.4
21.4
23
*
D39.11
ICD-10 Finland
Epithelial tumor of uncertain nature in the ovary
217.5
19.0
19
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
14.9
17.9
30
25
LAF00
NOMESCO Finland
Unilateral salpingo-oophorectomy
48.9
17.8
21
5
121
Kela drug reimbursment
Severe hypofunction of sexual glands
18.4
17.0
26
17
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
34.8
16.7
21
7
JAL00
NOMESCO Finland
Biopsy of peritoneum
51.1
15.5
18
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
4.0
13.5
84
380
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
27.3
12.8
17
7
WX302
NOMESCO Finland
Thoracal epidural anesthesy
8.8
12.5
27
37
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
4.4
11.9
49
151
A04AA01
ATC
ondansetron; systemic, rectal
7.2
11.7
29
49
B01AB10
ATC
tinzaparin; parenteral
7.3
11.1
27
44
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
9.7
10.5
21
25
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
18.4
10.1
15
9
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
59.1
9.8
11
*
B01AB05
ATC
enoxaparin; parenteral
3.2
9.5
68
318
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
+∞
9.5
9
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.2
8.9
28
64
1830A
ICD-9 Finland
Malignant neoplasm of ovary and other uterine adnexa, Ovary
53.4
8.8
10
*
C567
ICD-10 Finland
NA
53.4
8.8
10
*
D39.19
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary with unspecified histology
53.4
8.8
10
*
Z31.5
ICD-10 Finland
Genetic counselling
6.5
8.6
22
39
C56.79
ICD-10 Finland
Other epithelial carcinoma of the ovary
95.5
8.5
9
*
D27.91
ICD-10 Finland
Benign epithelial tumor of the ovary (ovary)
14.2
8.1
13
10
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
3.7
8.0
37
123
D39.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ovary
84.3
7.5
8
*
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
42.1
6.8
8
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
73.0
6.5
7
*
H02AB02
ATC
dexamethasone; systemic
3.7
6.4
28
88
JN4BD
NOMESCO Finland
Extensive body CT
4.0
6.3
25
72
18301
ICD-8 Finland
Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
45
143
4.06
12.81
1.8
4.2
17.6
10.0
ug/l
0.38
37
115
9
16
5.91
3.72
1.0
1.3
—
—
—
0
0
7
17
4.26
2.39
1.1
1.7
—
—
—
0
0
126
1373
0.50
2.31
11.8
10.0
23.4
23.5
u/l
0.03
118
1322
6
13
4.76
2.29
1.2
1.8
—
—
—
0
0
118
1306
0.56
2.12
14.6
12.8
27.9
19.5
mg/l
1.77
99
1014
112
1255
0.58
2.07
6.3
5.4
1.8
1.8
mu/l
0.02
102
1152
6
15
4.12
2.06
1.2
1.7
—
—
—
0
0
5
12
4.27
1.84
1.2
1.8
—
—
—
0
0
114
1257
0.62
1.64
3.9
4.5
5.9
5.8
mmol/l
0.31
97
1162
5
14
3.65
1.63
2.0
1.4
—
—
—
0
0
21
123
1.82
1.61
13.6
5.3
1.7
1.5
mmol/l
0.06
16
105
119
1296
0.61
1.55
4.3
5.0
2.9
2.8
mmol/l
0.52
105
1200
5
15
3.41
1.53
1.0
1.1
—
—
—
0
0
86
999
0.68
1.53
4.0
4.1
14.2
11.8
mm/h
0.72
80
905
6
139
0.41
1.48
2.2
1.8
—
—
—
0
0
108
1197
0.66
1.46
4.7
5.5
39.4
39.3
mmol/mol
0.05
98
1113
117
1274
0.64
1.42
3.7
4.4
4.9
4.8
mmol/l
0.28
104
1188
5
17
3.00
1.37
1.2
1.6
—
—
—
0
0
112
1225
0.67
1.29
15.3
12.4
83.0
80.7
ml/min/173m2
0.57
92
1004
16
257
0.58
1.26
1.5
1.5
—
—
—
0
0
22
325
0.62
1.24
1.2
1.2
0.8
2.2
u/ml
—
7
93
8
151
0.50
1.22
2.0
2.0
—
—
—
0
0
70
825
0.72
1.20
2.5
3.2
—
—
—
0
0
6
26
2.36
1.20
1.8
1.5
—
—
—
0
0
5
20
2.55
1.16
1.8
1.5
—
—
—
0
0
125
1330
0.65
1.10
18.4
14.5
3.9
3.9
mmol/l
0.37
120
1290
7
33
2.17
1.07
1.3
1.1
—
—
—
0
0
9
49
1.89
1.00
1.3
2.4
1.0
1.1
%
—
9
49
10
171
0.56
0.99
2.3
2.0
2.1
2.4
g/l
—
10
158
0
29
0.00
0.99
0.0
1.4
—
—
—
0
0
0
29
0.00
0.99
0.0
1.4
—
—
—
0
0
0
29
0.00
0.99
0.0
1.4
—
—
—
0
0
129
1359
0.65
0.97
18.1
15.1
66.8
69.0
umol/l
0.82
129
1359
19
126
1.58
0.97
1.7
1.7
—
—
—
0
0
118
1262
0.70
0.95
3.7
4.4
1.6
1.6
mmol/l
0.16
103
1170
6
27
2.27
0.94
1.2
1.2
—
—
—
0
0
6
27
2.27
0.94
1.2
1.2
—
—
—
0
0
19
127
1.57
0.94
1.6
1.8
—
—
—
0
0
112
1206
0.72
0.91
3.4
3.9
1.3
1.2
mmol/l
0.37
97
1111
6
29
2.11
0.90
1.8
1.4
—
—
—
0
0
26
190
1.45
0.86
4.0
3.0
3.2
4.1
e6/l
0.21
14
98
14
91
1.59
0.78
4.3
3.1
6.3
6.0
kpa
0.57
14
91
63
717
0.79
0.69
7.5
5.4
9.3
9.8
umol/l
0.48
58
675
69
605
1.26
0.68
3.8
3.8
—
—
—
0
0
10
62
1.66
0.67
20.9
5.9
1.5
1.3
%
—
10
62
10
62
1.66
0.67
21.6
5.9
0.7
0.7
%
—
10
62
9
141
0.62
0.64
2.0
1.5
1.3
1.3
%
—
9
123
16
219
0.70
0.63
5.1
3.7
180.5
85.6
ng/l
0.23
16
167
8
49
1.67
0.63
3.4
3.1
45.1
40.8
%
—
8
49
67
592
1.24
0.60
7.8
4.5
1.2
1.2
mmol/l
0.59
58
534
110
1166
0.79
0.58
17.9
13.8
39.6
39.5
%
0.05
72
852
73
656
1.22
0.55
8.2
5.0
1.2
1.2
mmol/l
0.63
59
546
24
190
1.31
0.52
1.8
1.8
—
—
—
0
0
41
468
0.83
0.42
4.9
3.1
2.4
2.4
mmol/l
0.70
32
409
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
25
206
1.26
0.41
3.6
2.7
1.0
1.2
e6/l
0.17
13
113
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
5
35
1.44
0.39
1.0
1.1
—
1.2
—
0
7
5
36
1.40
0.38
3.2
2.2
—
—
—
0
0
34
293
1.21
0.38
1.9
2.0
—
—
—
0
0
47
523
0.85
0.36
2.0
1.9
97.4
100.9
pmol/l
0.18
20
240
11
82
1.37
0.35
1.4
1.5
—
—
—
0
0
30
346
0.83
0.34
3.1
3.2
435.0
1205.0
ng/l
2.70
25
294
53
580
0.87
0.32
1.9
2.3
78.0
79.9
nmol/l
0.16
44
514
15
185
0.79
0.32
2.1
2.0
12.2
12.8
umol/l
0.09
15
171
47
518
0.87
0.31
4.9
3.9
—
—
—
0
0
79
839
0.88
0.30
3.2
2.9
48.7
39.8
u/l
0.40
68
784
7
55
1.29
0.30
1.1
1.5
—
—
—
0
0
98
1024
0.88
0.28
7.3
6.8
80.4
76.9
u/l
0.38
88
940
43
473
0.87
0.28
3.1
3.7
19.6
34.0
ng/l
0.88
29
320
59
547
1.13
0.26
5.1
3.8
35.0
35.8
g/l
0.39
54
510
41
451
0.88
0.26
4.7
3.1
—
—
—
0
0
16
133
1.23
0.25
8.3
3.0
1.0
1.0
mmol/l
0.18
16
118
77
729
1.11
0.24
8.2
3.9
6.5
6.5
mmol/l
0.03
70
669
11
89
1.25
0.21
9.1
3.5
4.6
4.4
pmol/l
0.51
11
77
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
245.8
—
0
11
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
61
647
0.90
0.21
5.0
3.8
0.0
0.0
estimate
0.00
16
138
14
165
0.83
0.20
3.9
4.4
34.8
34.6
%
—
5
107
7
58
1.22
0.18
28.7
3.7
25.3
25.1
mmol/l
—
7
58
24
266
0.88
0.17
1.3
1.3
59.7
35.4
iu/ml
—
7
100
12
101
1.20
0.17
1.8
2.4
66.8
69.9
ng/l
0.10
12
85
12
101
1.20
0.17
2.5
1.6
—
—
—
0
0
73
762
0.92
0.17
12.7
8.6
3.8
4.0
e9/l
0.26
56
670
8
70
1.15
0.16
1.1
1.7
—
—
—
0
0
23
249
0.91
0.11
1.8
1.7
1303.0
1170.4
nmol/l
0.16
11
187
30
320
0.92
0.11
1.3
1.4
—
—
—
0
0
106
1078
0.94
0.08
5.3
4.6
15.3
14.8
pmol/l
1.14
96
975
34
356
0.94
0.07
5.1
3.0
0.1
0.5
e6/l
1.55
25
263
7
82
0.85
0.07
2.3
1.3
—
—
—
0
0
13
119
1.10
0.06
9.5
4.1
324.6
249.9
u/l
0.33
13
112
64
654
0.96
0.05
7.1
5.2
0.0
0.0
estimate
0.00
15
138
65
659
0.98
0.02
4.8
3.8
0.0
0.0
estimate
0.00
16
134
13
123
1.06
0.01
4.1
3.5
—
—
—
0
0
41
409
1.00
0.00
3.4
2.2
55.2
54.0
u/l
0.05
36
373
35
348
1.01
0.00
4.3
4.2
0.0
0.0
estimate
0.00
14
140
27
268
1.01
0.00
1.2
1.3
4.7
12.9
u/ml
0.98
11
105
0
6
0.00
0.00
0.0
1.0
—
10.7
—
0
6
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
0
8
0.00
0.00
0.0
5.0
—
—
—
0
0
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
3.2
—
121.0
—
0
5
6
66
0.91
0.00
1.8
1.5
—
—
—
0
0
15
150
1.00
0.00
4.5
6.4
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
153.4
—
0
5
0
6
0.00
0.00
0.0
1.0
—
6.3
—
0
6
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
111.3
—
0
6
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
2.3
—
629.8
—
0
6
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_OVARY_MUCINO – Mucinous and mucinous cystic tumor
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).